Navigation Links
European Commission Approves DuPont Tender Offer to Acquire Danisco
Date:4/5/2011

COPENHAGEN, Denmark, April 5, 2011 /PRNewswire/ -- The European Commission (EC) has approved, under the European Union Merger Regulation, the tender offer by DuPont Denmark Holding ApS to acquire all of the outstanding shares of Danisco at a price of DKK 665 in cash per share. DuPont Denmark Holding ApS is a wholly owned and fully controlled subsidiary of DuPont (NYSE: DD).

"We are pleased to have achieved one of the last important milestones in the pending acquisition of Danisco," said DuPont Chair and CEO Ellen Kullman. "Only Chinese approval now remains as a regulatory condition of closing. We remain confident that Danisco shareholders will follow their Board's recommendation to accept our premium cash offer and the transaction will be completed later this month."

The EC approval satisfies another major condition of the tender offer.  Competition approval has already been obtained in the United States and similar regulatory approval in China is progressing.  The offer period ends on April 29, 2011, at 11 p.m. CEST (5 p.m. EDT), unless further extended as described in the offer document.  

All terms and conditions of the offer are described in the offer document, which is available free of charge at www.dupontanddanisco.com or on the Danisco website at www.danisco.com with a copy of the statement of the board of directors of Danisco A/S Concerning the Voluntary Recommended Public Offer. 

DuPont (www.dupont.com) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 90
'/>"/>

SOURCE DuPont
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
2. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
3. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
4. ApoA-I Data Presented at European Society of Cardiology Congress
5. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
6. Kuvan Receives Positive Opinion From CHMP for European Approval
7. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
8. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
9. European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
10. PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
11. Oslo and Toulouse Cancer Clusters Join Forces to Drive European Cancer Research Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 ITRA Global, one of the ... commercial real estate, has further expanded its global reach ... and Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman ... ITRA Global / ACORPP (Australian Corporate Property and Projects) ... providing property services to a wide range of clients ...
(Date:12/19/2014)... 19, 2014 Naurex Inc., a biopharmaceutical company ... diseases of the central nervous system, today announced that ... officer, will present at the 33 rd annual ... place at 3:00 p.m. PST on Tuesday, January 13, ... San Francisco, Calif. About ...
(Date:12/19/2014)... 2014 BioPlus Specialty Pharmacy ... pharmacies, has an expanded team of Regional Pharmaceutical ... for prescriber offices in their regions, with specific ... have a variety of Regional Pharmaceutical Care Liaisons ... in hepatitis C help prescribers understand all the ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
Breaking Biology Technology:ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... MENLO PARK, Calif., June 3 Kornberg Associates | ... to design the research areas of the new Malaysia ... announcement. , , The Malaysia Genome ... research organization launched by the Malaysian government in April ...
... InterMune, Inc. (Nasdaq: ITMN ) today announced ... InterMune, will present at the Goldman Sachs 30th Annual Global ... 2:35 p.m. ET. , , To access ... interested parties may log on to the investor relations page ...
... the House Nancy Pelosi (D-CA) apparently couldn,t resist injecting divisive ... of President Ronald Reagan today on Capital Hill. And ... misleading people again, this time with her statements on stem ... http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , , In discussing Nancy ...
Cached Biology Technology:Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute 2
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... Krustrup and his colleagues from the University of Copenhagen, the ... team consisting of 14 untrained men aged 20 to 40 ... players have been subjected to a number of tests such ... blood pressure, insulin sensitivity and balance. Surprising results ...
... University of Illinois at Chicago have discovered a chemical compound ... -- the first time in any species that an entire ... one sex. The research, performed using nuclear magnetic ... peer-reviewed, open-access resource from the Public Library of Science. ...
... Manhattan project in World War II, actinide,chemistry has ... still seek the ability to interpret and predict ... using first principle theory. Computational actinide chemistry may ... Jun Li will provide an overview of developments ...
Cached Biology News:Soccer burns more fat than jogging 2Soccer burns more fat than jogging 3First finding of a metabolite in 1 sex only 2
... Saccharomyces cerevisiae, as well as other yeasts, ... molecular biology laboratories. The ability to transform ... and linear DNAs using lithium based buffers ... transformations and library screening easy and reliable, ...
... jetSI-ENDO-FluoF is a ... nm; emission at 520 nm), ... These reagents are used to ... investigate the intracellular delivery and ...
... Designed specifically for high efficiency ... Low toxicity reagent proven to ... range of cell types. Results ... 95% of target gene expression. ...
... siRNA transfection reagent that has been shown ... variety of cell lines. jetSI-ENDO is serum ... protocol. High levels of gene silencing (up ... 20 to 100 nM of siRNA in ...
Biology Products: